Abstract

    Open Access Case Report Article ID: RAOA-1-107

    Remission of Glucocorticoid-Resistant Polymyalgia Rheumatica achieved with Tocilizumab: 2 Case Reports

    Ayse Unal Enginar*

    Polymyalgia rheumatica (PMR) is an idiopathic inflammatory disease characterized by pain and stiffness around the shoulders, neck and hips. IL-6 is an important cytokine in the pathogenesis of the disease. Although glucocorticoids (GC) are the current basic treatment, approximately 50% of patients may experience relapses during treatment. There have been case reports of resistant patients treated with Tocilizumab (TCZ), but as there has been insuffi cient evidence, the 2015 EULAR-ACR did not include TCZ treatment in the PMR recommendations.Two cases of GC-resistant PMR cases where remission was obtained with TCZ treatment are presented in this paper.

    Keywords:

    Published on: Nov 20, 2017 Pages: 25-27

    Full Text PDF Full Text HTML DOI: 10.17352/raoa.000007
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on RAOA

    Google Reviews 11